5-HT₂A receptor inactivation potentiates the acute antidepressant-like activity of escitalopram: involvement of the noradrenergic system. (Q45902720)

17 December 2017

title

5-HT₂A receptor inactivation potentiates the acute antidepressant-like activity of escitalopram: involvement of the noradrenergic system. (English)

1 reference

17 December 2017

1 reference

G Quesseveur

1

1 reference

17 December 2017

C Repérant

2

1 reference

17 December 2017

D J David

3

1 reference

17 December 2017

A M Gardier

4

1 reference

17 December 2017

C Sanchez

5

1 reference

17 December 2017

B P Guiard

6

1 reference

17 December 2017

publication date

15 February 2013

1 reference

17 December 2017

Experimental Brain Research

published in

1 reference

17 December 2017

volume

226

1 reference

17 December 2017

issue

2

1 reference

17 December 2017

page(s)

285-295

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1007/s00221-013-3434-3

exact match

0 references

cites work

Intracellular recording in vivo from serotonergic neurons in the rat dorsal raphe nucleus: methodological considerations.

1 reference

https://api.crossref.org/works/10.1007%2FS00221-013-3434-3

Neurobiological bases and clinical aspects of the use of aripiprazole in treatment-resistant major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-013-3434-3

A role for midbrain raphe gamma aminobutyric acid neurons in 5-hydroxytryptamine feedback control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-013-3434-3

Evidence that central 5-HT2A and 5-HT2B/C receptors regulate 5-HT cell firing in the dorsal raphe nucleus of the anaesthetised rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-013-3434-3

In vivo modulation of 5-hydroxytryptamine release in mouse prefrontal cortex by local 5-HT(2A) receptors: effect of antipsychotic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-013-3434-3

The role of noradrenaline and selective noradrenaline reuptake inhibition in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-013-3434-3

Monoaminergic changes in locus coeruleus and dorsal raphe nucleus following noradrenaline depletion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-013-3434-3

Second-generation antipsychotics in major depressive disorder: update and clinical perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-013-3434-3

Serotonin receptor 2A gene polymorphism (-1438A/G) and short-term treatment response to citalopram

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-013-3434-3

Noradrenergic lesions differentially alter the antidepressant-like effects of reboxetine in a modified forced swim test

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-013-3434-3

Utility of atypical antipsychotics in the treatment of resistant unipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-013-3434-3

The noradrenergic action in antidepressant treatments: pharmacological and clinical aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-013-3434-3

Synergistic dopamine increase in the rat prefrontal cortex with the combination of quetiapine and fluvoxamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-013-3434-3

Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-013-3434-3

Noradrenergic augmentation of escitalopram response by risperidone: electrophysiologic studies in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-013-3434-3

Distinct electrophysiological effects of paliperidone and risperidone on the firing activity of rat serotonin and norepinephrine neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-013-3434-3

Involvement of 5-HT2A receptor and α2-adrenoceptor blockade in the asenapine-induced elevation of prefrontal cortical monoamine outflow

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-013-3434-3

Role of 5-HT1A autoreceptors in the mechanism of action of serotoninergic antidepressant drugs: recent findings from in vivo microdialysis studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-013-3434-3

Inhibition of 5-hydroxytryptamine neuronal activity by the 5-HT agonist, DOI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-013-3434-3

Serotonin (5-HT)2A receptor activation enhances dialysate levels of dopamine and noradrenaline, but not 5-HT, in the frontal cortex of freely-moving rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-013-3434-3

Functional interactions between dopamine, serotonin and norepinephrine neurons: an in-vivo electrophysiological study in rats with monoaminergic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-013-3434-3

Altered response to the selective serotonin reuptake inhibitor escitalopram in mice heterozygous for the serotonin transporter: an electrophysiological and neurochemical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-013-3434-3

Behavioral effects of chronic fluoxetine in BALB/cJ mice do not require adult hippocampal neurogenesis or the serotonin 1A receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-013-3434-3

Augmentation by citalopram of risperidone-induced monoamine release in rat prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-013-3434-3

5-HT2A gene variants influence specific and different aspects of antidepressant response in Japanese and Italian mood disorder patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-013-3434-3

HTR2A is associated with SSRI response in major depressive disorder in a Japanese cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-013-3434-3

Brain region and dose effects of an olanzapine/fluoxetine combination on extracellular monoamine concentrations in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-013-3434-3

The relationship between single nucleotide polymorphisms in 5-HT2A signal transduction-related genes and the response efficacy to selective serotonin reuptake inhibitor treatments in Chinese patients with major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-013-3434-3

Serotonin 5-HT(2) receptors activate local GABA inhibitory inputs to serotonergic neurons of the dorsal raphe nucleus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-013-3434-3

HTR2A gene variation is involved in antidepressant treatment response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-013-3434-3

Allosteric modulation of the effect of escitalopram, paroxetine and fluoxetine: in-vitro and in-vivo studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-013-3434-3

5-HT2A receptor or alpha1-adrenoceptor activation induces excitatory postsynaptic currents in layer V pyramidal cells of the medial prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-013-3434-3

The selective 5-HT2A receptor antagonist M100907 enhances antidepressant-like behavioral effects of the SSRI fluoxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-013-3434-3

Frontal 5-HT2A receptors studied in depressive patients during chronic treatment by selective serotonin reuptake inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-013-3434-3

Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-013-3434-3

The effect of paroxetine on 5-HT(2A) receptors in depression: an [(18)F]setoperone PET imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-013-3434-3

A novel 5-HT(2A) receptor antagonist exhibits antidepressant-like effects in a battery of rodent behavioural assays: approaching early-onset antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-013-3434-3

The highly selective 5-hydroxytryptamine (5-HT)2A receptor antagonist, EMD 281014, significantly increases swimming and decreases immobility in male congenital learned helpless rats in the forced swim test

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-013-3434-3

Resequencing of serotonin-related genes and association of tagging SNPs to citalopram response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-013-3434-3

Forced swimming test in mice: a review of antidepressant activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-013-3434-3

Functional status of somatodendritic serotonin 1A autoreceptor after long-term treatment with fluoxetine in a mouse model of anxiety/depression based on repeated corticosterone administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-013-3434-3

Fluoxetine administration potentiates the effect of olanzapine on locus coeruleus neuronal activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-013-3434-3

Relevance of dorsal raphe nucleus firing in serotonin 5-HT(2C) receptor blockade-induced augmentation of SSRIs effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-013-3434-3

Functional and pharmacological characterization of the modulatory role of serotonin on the firing activity of locus coeruleus norepinephrine neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-013-3434-3

Modulation of noradrenergic neuronal firing by selective serotonin reuptake blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-013-3434-3

Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-013-3434-3

A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, and fluoxetine in treatment-resistant major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-013-3434-3

Electrophysiological and pharmacological characterization of serotonergic dorsal raphe neurons recorded extracellularly and intracellularly in rat brain slices

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-013-3434-3

Interaction between two HTR2A polymorphisms and gender is associated with treatment response in MDD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-013-3434-3

Cortical 5-HT2A receptor signaling modulates anxiety-like behaviors in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-013-3434-3

Polymorphisms in the SLC6A4 and HTR2A genes influence treatment outcome following antidepressant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-013-3434-3

Effects of a selective 5-HT2 agonist, DOI, on 5-HT neuronal firing in the dorsal raphe nucleus and 5-HT release and metabolism in the frontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-013-3434-3

Expression of 5-HT(2A) receptor mRNA in some nuclei of brain stem enhanced in monoarthritic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-013-3434-3

Increased 5-hydroxytryptamine-2 receptor binding in the frontal cortex of depressed patients responding to paroxetine treatment: a positron emission tomography scan study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-013-3434-3

Effects of serotonin (5-HT)2 receptor ligands on depression-like behavior during nicotine withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-013-3434-3

Suppression of firing activity of 5-HT neurons in the dorsal raphe by alpha-adrenoceptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-013-3434-3

Olanzapine/fluoxetine combination for treatment-resistant depression: a controlled study of SSRI and nortriptyline resistance.

21 January 2018

1 reference

12 December 2020

5-HT2 ligands in the treatment of anxiety and depression

1 reference

12 December 2020

The use of quetiapine for treatment-resistant bipolar disorder: a case series

1 reference

12 December 2020

The serotonergic and noradrenergic systems of the hippocampus: their interactions and the effects of antidepressant treatments

1 reference

12 December 2020

Risperidone augmentation of selective serotonin reuptake inhibitors in major depression.

1 reference

12 December 2020

An open pilot study combining risperidone and a selective serotonin reuptake inhibitor as initial antidepressant therapy.

1 reference

12 December 2020

Antisense inhibition of 5-hydroxytryptamine2a receptor induces an antidepressant-like effect in mice

1 reference

12 December 2020

Effects of acute and long-term administration of escitalopram and citalopram on serotonin neurotransmission: an in vivo electrophysiological study in rat brain

1 reference

12 December 2020

Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test

1 reference

12 December 2020

Blockade of the high-affinity noradrenaline transporter (NET) by the selective 5-HT reuptake inhibitor escitalopram: an in vivo microdialysis study in mice

1 reference

12 December 2020

Potential mechanisms of action of atypical antipsychotic medications in treatment-resistant depression and anxiety.

1 reference

12 December 2020

Control of serotonergic function in medial prefrontal cortex by serotonin-2A receptors through a glutamate-dependent mechanism.

1 reference

12 December 2020

Progressive attenuation of the firing activity of locus coeruleus noradrenergic neurons by sustained administration of selective serotonin reuptake inhibitors

1 reference

12 December 2020

Synergistic effects of olanzapine and other antipsychotic agents in combination with fluoxetine on norepinephrine and dopamine release in rat prefrontal cortex

1 reference

12 December 2020

10.1007/S00221-013-3434-3

Identifiers

DOI

1 reference

17 December 2017

Dimensions Publication ID

1021313219

0 references

1 reference

17 December 2017